about
Reporting of euthanasia and physician-assisted suicide in the Netherlands: descriptive studyDiagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysisTwo Decades of Research on Euthanasia from the Netherlands. What Have We Learnt and What Questions Remain?Patient representatives' contributions to the benefit-risk assessment tasks of the European Medicines Agency scientific committeesWhat do international ethics guidelines say in terms of the scope of medical research ethics?Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.When Children Become Adults: Should Biobanks Re-Contact?Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans.Dances with data.Aims and tasks in parental caregiving for children receiving palliative care at home: a qualitative study.Big Data in medical research and EU data protection law: challenges to the consent or anonymise approachA qualitative study on acceptable levels of risk for pregnant women in clinical research.Disclosure of individual genetic data to research participants: the debate reconsidered.The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methods.Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents.Stem cell trials for cardiovascular medicine: ethical rationale.Inclusion of residual tissue in biobanks: opt-in or opt-out?News media coverage of euthanasia: a content analysis of Dutch national newspapers.Phase IV non-inferiority trials and additional claims of benefit.Continuous deep sedation for patients nearing death in the Netherlands: descriptive studyPre-arrest predictors of survival after resuscitation from out-of-hospital cardiac arrest in the elderly a systematic review.Decisions to withhold diagnostic investigations in nursing home patients with a clinical suspicion of venous thromboembolism.Strengths and weaknesses of guideline approaches to safeguard voluntary informed consent of patients within a dependent relationship.Opinions about euthanasia and advanced dementia: a qualitative study among Dutch physicians and members of the general public.The social value of clinical research.End-of-life decision-making in Canada: the report by the Royal Society of Canada expert panel on end-of-life decision-making.The need to balance merits and limitations from different disciplines when considering the stepped wedge cluster randomized trial design.Considerations of physicians about the depth of palliative sedation at the end of life.Advance care planning--a multi-centre cluster randomised clinical trial: the research protocol of the ACTION studyValidation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis.Personalized assent for pediatric biobanks.A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology.Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?Opinions of the Dutch public on palliative sedation: a mixed-methods approach.What is the best standard for the standard of care in clinical research?Clarifying assent in pediatric researchThe fiduciary obligation of the physician-researcher in phase IV trials.Dutch experience of monitoring active ending of life for newborns.Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from 1990 to 2010: a repeated cross-sectional survey.A framework for the ethics review of education research.
P50
Q21254626-B4092E61-7511-4AD0-A4A2-7A2B2EFEC0FFQ24630476-F1A345E0-45EB-4DE8-9D02-1339272C5BD3Q24646327-FA158982-0B0C-4669-8D2A-0A830C87AE7BQ26866292-3755D471-0CCB-4FC8-8432-B955254F1071Q27308036-CE0C575B-BF77-4653-B0B1-402C906102F0Q27332116-E09D8591-3598-4B0B-BA50-6C57D122F2F4Q28080169-41F17420-356C-4C41-AA13-1BAC03423A22Q28578011-4FC9B4D9-AAD1-4B04-9AD1-E276E268487CQ30663224-F682050E-8408-4C22-B845-B5DA645FD9CCQ30839653-43AEE3C6-E35D-44A5-9DE0-D1BD372E4723Q31020801-7C5DA7C1-885D-4BF0-A4DF-7F30CC0485E2Q33691429-2C1934E5-E0DC-47D5-97A1-D5E7F0904512Q33781801-73E95A11-F32D-44C6-88F5-1E5BD1140184Q34240740-A50AA54B-955A-46D9-BB49-2B5551015457Q34322484-BB672330-B4A9-472E-B341-501018C07DE3Q34331206-EDAD4E0A-44D2-4144-BACC-36813C16B673Q34382331-BCDA0F9A-D2A5-4624-B06D-5F5208E01650Q34623139-84481395-4006-4254-B50A-F20C3667D7A3Q34747480-6D810D53-0470-49AE-85C5-1A085250B345Q34762108-94EE8C0C-3C9E-4D38-B6AB-F68FD24AE2E9Q34790468-98341AA3-C975-4D3D-B4AA-99BAA1DA2937Q35116580-7960521E-771A-488B-8FE1-8765D834F5D5Q35127377-5D4B6537-2220-405C-B80D-EA6132DDFC63Q35151401-0442F05C-4F91-4DCF-864B-9559000AF8A3Q35238851-10631865-B219-4566-9A6F-C0FCD4FE776CQ35693012-81B96C64-0BF6-49D1-8EA6-4D2847F20BEEQ35826614-69ED4A5E-EBD1-41D9-91C4-70F1A370610DQ35894580-B0130410-0BC9-4FD6-B020-61609A05B2FBQ35984068-527B47D2-24DD-4D8F-9751-DF80E9134FBAQ36011969-9AC098CC-35C0-4811-8E0C-EA8EB7EB0ED5Q36161881-B7365535-6659-4855-A925-A0233DF00AACQ36762473-F9B905A6-7698-476B-A419-1B240877E1B5Q36971364-986B8A6F-BCE1-43E3-A918-9A5C03C3BA7AQ37196830-101479ED-D59C-4A01-A9DA-94957C7630DDQ37402541-5EB3B817-F869-48ED-98CD-68AA8B85ECFFQ37493074-707175CC-5F94-4A96-8991-4707C3D11266Q37580151-7B04EC40-C3AF-4918-A18C-263B6D7E1FF5Q37719192-903B3894-BCB2-4C91-B79E-CEB587599379Q38025773-D286B6EC-EDA8-4257-8376-304671BE9CDFQ38026884-52D250E7-48DF-486E-A127-8804181F3179
P50
name
Johannes van Delden
@ast
Johannes van Delden
@en
Johannes van Delden
@es
Johannes van Delden
@fr
Johannes van Delden
@nl
type
label
Johannes van Delden
@ast
Johannes van Delden
@en
Johannes van Delden
@es
Johannes van Delden
@fr
Johannes van Delden
@nl
prefLabel
Johannes van Delden
@ast
Johannes van Delden
@en
Johannes van Delden
@es
Johannes van Delden
@fr
Johannes van Delden
@nl